National Institutes of Health
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
Translational Neural Devices (R61/R33 - Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing January 28, 2027.
Overview
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program…